Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Ampio spins off sexual dysfunction business into new company

Dec. 17, 2013

FDA approves Xiaflex for Peyronie's disease

Dec. 9, 2013

Novel phosphate adsorbers for the treatment of patients with renal failure

Dec. 5, 2013

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

MPO inhibitor PF-1355 demonstrates significant attenuation of cardiovascular and renal disorders

Nov. 22, 2013

European Commission approves Prilocaine Lidocaine Plethora for premature ejaculation

Nov. 19, 2013

Toray Industries divulges novel soluble epoxide hydrolase inhibitors

Nov. 18, 2013

Kyowa Hakko Kirin discontinues phase II studies of bardoxolone methyl

Nov. 12, 2013

Keryx Biopharmaceuticals provides update from safety extension study of Zerenex

Nov. 12, 2013

New Hsp70 inducers presented by scientists in the Netherlands

Nov. 11, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...